Skip to content
Back to announcement

20230731_LPKR_Laporan Informasi dan Fakta Material_31355499_lamp1.pdf

Other Text extracted LPKR

Source file signed link, expires in 15 minutes

This browser can't display the PDF inline. Open it in a new tab.

Extracted text 2

Page 1
- LPKR ACHIEVES NET PROFIT OF IDR 1.1TN IN SEMESTER I/2023

- LPKR’S REVENUE REACHES IDR 8.1TN WITH A NET PROFIT OF IDR
1.1TN IN SEMESTER I/2023

- DRIVEN BY IMPROVED PERFORMANCE ACROSS ALL BUSINESS
SEGMENTS, LPKR ACHIEVES NET PROFIT OF IDR 1.1TN IN
SEMESTER I/2023

Jakarta, 31 July 2023 – PT Lippo Karawaci Tbk. (LPKR), Indonesia’s leading real estate and
healthcare platform, has achieved a 19% YoY revenue growth to IDR 8.1tn in Semester I/2023.
Gross profit also increased by 21% YoY to IDR 3.5tn, and EBITDA grew by 39% YoY to IDR
2tn. LPKR also successfully recorded a net profit of IDR 1.1tn in Semester I/2023, which reflected
a significant turnaround from net loss position of -IDR 1.2tn in Semester I/2022.

Moreover, in Q2/2023 LPKR successfully achieved a net profit of IDR 12bn without any
extraordinary events affecting its results. This achievement marks the first positive net profit since
Q1/2019 that was solely driven by the improved fundamental performance of the business.
Management believes this trend is likely to sustain, driven by improved performance across all
business segments.

In the real estate segment, LPKR achieved a successful marketing sale of IDR 2.48tn, supported
by a diverse product offering and consistent product launches. This accomplishment fulfills 50.6%
of the marketing sales target of IDR 4.9tn for the year 2023.

LPKR’s healthcare segment, operated by its subsidiary PT Siloam International Hospitals Tbk
(“Siloam”), maintained strong financial growth momentum during Semester I/2023. In this period,
the revenue from the healthcare segment grew by 20% YoY, and EBITDA increased by 48% YoY.
This achievement was driven by a robust recovery in non-Covid-19 related revenue, increased
patient volumes, and the improved adoption of Siloam’s digital channels, which provide easier
access for patients.

Meanwhile, the lifestyle segment continued to benefit from post-Covid recovery, with revenue and
EBITDA increasing by 14% and 20% YoY, respectively, in Semester I/2023.

Group CEO LPKR, John Riady, stated, "We proudly present our performance during Semester
I/2023, reflecting the success of our turnaround efforts. Particularly in Q2/2023, we achieved net
profit without any extraordinary events affecting the results. This accomplishment demonstrates
the improved fundamental performance of all our business units. We expect this positive trend to
continue going forward. As we enter Q3/2023, we remain committed to offering new and diverse
Page 2
products to meet various pockets of demands while maintaining timely product deliveries and
sustaining the strong growth in our healthcare and lifestyle businesses."

File

File Open PDF
Source IDX
Size0.14 MB
Published31 Jul 2023
Pages2
Characters2,663
Text sourceEmbedded text layer
OCR confidence—

Names mentioned 0 people and organisations named in the text · linked when the evidence is strong

The name pass has not read this document yet.

Extraction attempts how the parser did, and what it refused

Nothing structured was extracted from this document — the attempts below say why.

No extraction attempted yet.

↑↓ select ↵ open ⇧↵ see every result